Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Oculus Innovative Sciences Inc Receives CE Mark for use of Microcyn


Tuesday, 4 Feb 2014 08:08am EST 

Oculus Innovative Sciences Inc:Receives the European CE Mark for the Microcyn -based GramaDerm Solution and GramaDerm Hydrogel.Both products are intended for use in the topical treatment of mild to moderate acne and are designed to complement other acne treatments. 

Company Quote

1.49
-0.01 -0.67%
26 Dec 2014